LncRNA XIST has been found to be highly expressed in liver tissue of ALD patients and reduces miR-29b inhibition of COL1A1 and α-SMA by competitively binding to miR-29b, which in turn promotes collagen synthesis and HSC activation and exacerbates liver fibrosis.[28]. Here, COL1A1 is linked to Hepatic fibrosis.